Author details

Full Name

Yutaka Tamada

Affiliation

Jyoban Hospital, Tokiwa Foundation

ORCID

Career Start Year

1993

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34641504	A Possible Inhibitory Role of Sialic Acid on MUC1 in Peritoneal Dissemination of Clear Cell-Type Ovarian Cancer Cells.	Molecules	2021
26443563	The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer.	Clin Exp Metastasis	2015
22392500	Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells.	Tumour Biol	2012
19048625	Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.	Int J Cancer	2009
19687598	Combination of abducens nerve palsy and ipsilateral postganglionic Horner syndrome as an initial manifestation of uterine cervical cancer.	Intern Med	2009
19270491	Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity.	Autophagy	2009
18028379	Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen.	Int J Gynecol Cancer	2008
18259115	Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3.	Autophagy	2008
17711507	Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary.	Cancer Sci	2007
16338478	8-1A, a human monoclonal antibody that reacts with intact human chorionic gonadotropin.	Placenta	2006
17476974	Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.	Oncol Res	2006
16681764	Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer.	Int J Gynecol Cancer	2006
15670300	Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers.	Int J Gynecol Cancer	2005
17022146	Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.	Hum Cell	2005
14687800	Model for paraaortic lymph node metastasis produced by orthotopic implantation of ovarian carcinoma cells in athymic nude mice.	Eur J Cancer	2004
15535271	[Conservative hormonal therapy for endometrial cancer].	Nihon Rinsho	2004
15491748	HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.	Gynecol Oncol	2004
10608618	Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines.	Oncol Res	1999
8112710	[The biological activities of the human papillomavirus type 16 E6/E7 cDNAs cloned from the SiHa cervical carcinoma cell line].	Hokkaido Igaku Zasshi	1993

1 - 19 of 19

Yingmei Wang

Tianjin Medical University General Hospital

Career Start Year 2007

Number of shared co-authors 0

Shin-Wha Lee

Asan Medical Center, University of Ulsan College of Medicine

Career Start Year 2006

Number of shared co-authors 0

Sven Mahner

University Hospital

Career Start Year 2002

Number of shared co-authors 0

Aparna A Kamat

Houston Methodist Hospital

Career Start Year 2000

Number of shared co-authors 0

Paulette Mhawech-Fauceglia

University of Southern California

Career Start Year 1995

Number of shared co-authors 0

Amy Ziober

Hospital of the University of Pennsylvania

Career Start Year 1995

Number of shared co-authors 0

Sang Yong Song

Center for Nanophase Materials Sciences, Oak Ridge National Laboratory

Career Start Year 1995

Number of shared co-authors 0

Yong-Man Kim

Asan Medical Center, University of Ulsan College of Medicine

Career Start Year 1994

Number of shared co-authors 0

Denise C Connolly

Fox Chase Cancer Center

Career Start Year 1993

Number of shared co-authors 0

Ernst Lengyel

University of Chicago

Career Start Year 1993

Number of shared co-authors 1

Barry R Davies

Oncology R&D

Career Start Year 1992

Number of shared co-authors 1

Sandra Orsulic

David Geffen School of Medicine, University of California at Los Angeles

Career Start Year 1992

Number of shared co-authors 1

Anil K Sood

The University of Texas MD Anderson Cancer Center

Career Start Year 1991

Number of shared co-authors 2

Rosemarie Schmandt

The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center

Career Start Year 1991

Number of shared co-authors 1

Gustavo C Rodriguez

Clinica Quirurgica 2 (Surgical Clinic 2), Hospital Maciel

Career Start Year 1990

Number of shared co-authors 1

Kathleen M Darcy

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Career Start Year 1990

Number of shared co-authors 0

Patricia A Shaw

Princess Margaret Cancer Centre, University Avenue

Career Start Year 1990

Number of shared co-authors 1

Roger Chammas

Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo

Career Start Year 1989

Number of shared co-authors 0

Tanja Pejovic

Oregon Health & Science University

Career Start Year 1989

Number of shared co-authors 1

Cyril B Gilks

University of British Columbia

Career Start Year 1987

Number of shared co-authors 1

Ossama Tawfik

University of Kansas

Career Start Year 1985

Number of shared co-authors 0

Yao-Tseng Chen

From Population Health Services (Chen)

Career Start Year 1984

Number of shared co-authors 0

Gary L Keeney

Mayo Clinic

Career Start Year 1984

Number of shared co-authors 1

Andrew Berchuck

Duke School of Medicine

Career Start Year 1983

Number of shared co-authors 1

Beth Y Karlan

David Geffen School of Medicine, University of California los angeles

Career Start Year 1981

Number of shared co-authors 1

Ronny Drapkin

University of Pennsylvania School of Medicine

Career Start Year 1980

Number of shared co-authors 1

Jahn M Nesland

The Norwegian Radium Hospital, Oslo University Hospital

Career Start Year 1980

Number of shared co-authors 0

Bernard T??tu

Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)

Career Start Year 1979

Number of shared co-authors 0

Fabien Calvo

Universite de Paris-Cite

Career Start Year 1979

Number of shared co-authors 0

Bogdan Czerniak

University of Texas MD Anderson Cancer Center

Career Start Year 1975

Number of shared co-authors 3

row(s) 1 - 30 of 30

Takashi Shingu

The University of Texas MD Anderson Cancer Center

Co-authored papers 3

Seiji Kondo

Fukuoka University

Co-authored papers 3

Tomohisa Yokoyama

Kohsei Chuo General Hospital.

Co-authored papers 3

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 3

Naoki Shinojima

Kumamoto University Hospital

Co-authored papers 3

Kouzo Moritake

Shimane University School of Medicine

Co-authored papers 2

Yasuhiko Akiyama

Shimane University Hospital

Co-authored papers 2

Keishi Fujiwara

University of Texas M.D. Anderson Cancer Center